Related references
Note: Only part of the references are listed.microRNA 223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1
Mirte Mayke Streppel et al.
CLINICAL CANCER RESEARCH (2013)
The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia
Marc R. Mansour et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Catecholamine-Induced β2-Adrenergic Receptor Activation Mediates Desensitization of Gastric Cancer Cells to Trastuzumab by Upregulating MUC4 Expression
Ming Shi et al.
JOURNAL OF IMMUNOLOGY (2013)
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
Y. Y. Janjigian et al.
ANNALS OF ONCOLOGY (2012)
Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma
J. Kurashige et al.
BRITISH JOURNAL OF CANCER (2012)
MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4
Jinhai Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
miR-23a Promotes the Transition from Indolent to Invasive Colorectal Cancer
Sohail Jahid et al.
CANCER DISCOVERY (2012)
Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas
Qingguo Li et al.
BMC CANCER (2011)
MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
Naohiro Nishida et al.
CLINICAL CANCER RESEARCH (2011)
Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer
Chang Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
Maria D. Begnami et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hiroyuki Inuzuka et al.
NATURE (2011)
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E. Wertz et al.
NATURE (2011)
Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen
Q. Wang et al.
ONCOGENE (2011)
Survival prediction of gastric cancer by a seven-microRNA signature
Xiaohua Li et al.
GUT (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
Takehiko Yokobori et al.
CANCER RESEARCH (2009)
MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma
Yukiharu Hiyoshi et al.
CLINICAL CANCER RESEARCH (2009)
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
Jeffrey S. Ross et al.
ONCOLOGIST (2009)
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
C. Gravalos et al.
ANNALS OF ONCOLOGY (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
FBXW7/hCDC4 is a general tumor suppressor in human cancer
Shahab Akhoondi et al.
CANCER RESEARCH (2007)
Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus
Uta Reichelt et al.
MODERN PATHOLOGY (2007)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Amplification of HER-2 in gastric carcinoma:: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
M Tanner et al.
ANNALS OF ONCOLOGY (2005)
Inactivation of hCDC4 can cause chromosomal instability
H Rajagopalan et al.
NATURE (2004)
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata et al.
CANCER CELL (2004)
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene
JH Mao et al.
NATURE (2004)
Expression of the HERI-4 family of receptor tyrosine kinases in breast cancer
CJ Witton et al.
JOURNAL OF PATHOLOGY (2003)
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer
FJ Esteva et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)
YH Lu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
